Methylmercury-Induced Inhibition of Paraoxonase-1 (PON1)—Implications for Cardiovascular Risk

REFERENCES

• Agency for Toxic Substances and Disease Registry. 2013. Addendum to the toxicological profile for mercury (alkyl and dialkyl compounds). http://www.atsdr.cdc.gov/toxprofiles/mercury_organic_addendum.pdf (accessed December 2, 2013).
   Google Scholar
• Aguado, A., Galán, M., Zhenyukh, O., Wiggers, G. A., Roque, F. R., Redondo, S., Peçanha, F., Martín, A., Fortuño, A., Cachofeiro, V., Tejerina, T., Salaices, M., and Briones, A. M. 2013. Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. Toxicol. Appl. Pharmacol. 268: 188–200.
   PubMed Web of Science ®Google Scholar
• Anderson, H. A., Hanrahan, L. P., Smith, A., Draheim, L., Kanarek, M., and Olsen, J. 2004. The role of sport-fish consumption advisories in mercury risk communication: A 1998–1999 12-state survey of women age 18–45. Environ. Res. 95: 315–324.
   PubMed Web of Science ®Google Scholar
• Araoud, M., Neffeti, F., Douki, W., Najjar, M. F., and Kenani, A. 2010. Paraoxonase 1 correlates with butyrylcholinesterase and gamma glutamyl transferase in workers chronically exposed to pesticides. J. Occup. Health 52: 383–388.
   PubMed Web of Science ®Google Scholar
• Aslan, M., Nazligul, Y., Horoz, M., Bolukbas, C., Bolukbas, F. F., Gur, M., Celik, H., and Erel, O. 2008. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects. Atherosclerosis 196: 270–274.
   PubMed Web of Science ®Google Scholar
• Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., and La Du, B. 1998. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18: 1617–1624.
   PubMed Web of Science ®Google Scholar
• Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C. L., Newton, R. S., and La Du, B. 1999. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biol. Med. 26: 892–904.
   PubMed Web of Science ®Google Scholar
• Ayotte, P., Carrier, A., Ouellet, N., Boiteau, V., Abdous, B., Sidi, E. A., Château-Degat, M. L., Dewailly, É. (2011). Relation between methylmercury exposure and plasma paraoxonase activity in inuit adults from Nunavik. Environ. Health Perspect. 119: 1077–1083.
   PubMed Web of Science ®Google Scholar
• Bagchi, D., Bagchi, M., Hassoun, E. A., and Stohs, S. J. 1995. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 104: 129–140.
   PubMed Web of Science ®Google Scholar
• Banerjee, I. 2010. Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: A meta-analysis. Eur. J. Epidemiol. 25:449–458.
   PubMed Web of Science ®Google Scholar
• Bayrak, A., Bayrak, T., Demirpençe, E., and Kılınç, K. 2011. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879: 49–55.
   PubMed Web of Science ®Google Scholar
• Bayrak, A., Bayrak, T., Tokgözoglu, S. L., Volkan-Salanci, B., Deniz, A., Yavuz, B., Alikasifoglu, M., and Demirpençe, E. 2012. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis. J. Atheroscler. Thromb. 19: 376–384.
   PubMed Web of Science ®Google Scholar
• Bayram, F., Kocer, D., Ozsan, M., and Muhtaroglu, S. 2012. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: Relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction. Gynecol. Endocrinol. 28: 497–501.
   PubMed Web of Science ®Google Scholar
• Bellinger, D. C. 2007. Interpretation of small effect sizes in occupational and environmental neurotoxicology: individual versus population risk. Neurotoxicology 28: 245–251.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, T., Nicholls, S. J., Topol, E. J., Zhang, R., Yang, X., Schmitt, D., Fu, X., Shao, M., Brennan, D. M., Ellis, S. G., Brennan, M. L., Allayee, H., Lusis, A. J., and Hazen, S. L. 2008. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. J. Am. Med. Assoc. 299: 1265–1276.
   PubMed Web of Science ®Google Scholar
• Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., La Du, B. N. 2000. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 28: 1335–1342.
   PubMed Web of Science ®Google Scholar
• Chang, M. H., Yesupriya, A., Ned, R. M., Mueller, P. W., and Dowling, N. F. 2010. Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey. BMC Med. Genet. 11: 62.
   PubMedGoogle Scholar
• Cherki, M., Berrougui, H., Isabelle, M., Cloutier, M., Koumbadinga, G. A., and Khalil, A. 2007. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging. Exp. Gerontol. 42: 815–824.
   PubMed Web of Science ®Google Scholar
• Choi, A. L., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., Salonen, J. T., Tuomainen, T. P., Murata, K., Nielsen, H. P., Petersen, M. S., Askham, J., and Grandjean, P. 2009. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ. Health Perspect. 117: 367–372.
   PubMed Web of Science ®Google Scholar
• Counter, S. A., Buchanan, L. H., Ortega, F., and Laurell, G. 2002. Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines. J. Toxicol. Environ. Health A 65: 149–163.
   PubMed Web of Science ®Google Scholar
• Cole, T. B., Li, W. F., Richter, R. J., Furlong, C. E., and Costa, L. G. 2002. Inhibition of paraoxonase (PON1) by heavy metals. Toxicol. Sci. 66( suppl. 1): 312 [Abstract].
   Google Scholar
• Costa, L. G., Cole, T. B., Jarvik, G. P., and Furlong, C. E. 2003. Functional genomic of the paraoxonase (PON1) polymorphisms: Effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54: 371–392.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., Vitalone, A., Cole, T. B., and Furlong, C. E. 2005. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69: 541–550.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., Giordano, G., and Furlong, C. E. 2011. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on. Biochem. Pharmacol. 81: 337–344.
   PubMed Web of Science ®Google Scholar
• Dahabreh, I. J., Kitsios, G. D., Kent, D. M., and Trikalinos, T. A. 2010. Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet. Med. 12: 606–615.
   PubMed Web of Science ®Google Scholar
• Deakin, S. P., and James, R. W. 2004. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci. 107: 435–447.
   PubMed Web of Science ®Google Scholar
• Debord, J., Bollinger, J. C., Merle, L., and Dantoine, T. 2003. Inhibition of human serum arylesterase by metal chlorides. J. Inorg. Biochem. 94: 1–4.
   PubMed Web of Science ®Google Scholar
• Dilek, E. B., Küfrevioğlu, O. I., and Beydemir, S. 2013. Impacts of some antibiotics on human serum paraoxonase 1 activity. J. Enzyme Inhib. Med. Chem. 28: 758–764.
   PubMed Web of Science ®Google Scholar
• Efrat, M., and Aviram, M. 2010. Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis—A protective role for HDL phospholipids. Adv. Exp. Med. Biol. 660:153–166.
   PubMed Web of Science ®Google Scholar
• Ferré, N., Camps, J., Cabré, M., Paul, A., and Joven, J. 2001. Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism 50: 997–1000.
   PubMed Web of Science ®Google Scholar
• Ferré, N., Camps, J., Fernández-Ballart, J., Arija, V., Murphy, M. M., Marsillach, J., and Joven, J. 2006. Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy. Clin. Chem. Lab. Med. 44: 880–882.
   PubMed Web of Science ®Google Scholar
• Ferretti, G., Bacchetti, T., Saturni, L., Manzella, N., Candelaresi, C., Benedetti, A., and Di Sario, A. 2012. Lipid peroxidation and paraoxonase-1 activity in celiac disease. J. Lipids article ID 587479.
   Google Scholar
• Franco-Pons, N., Marsillach, J., Joven, J., Camps, J., and Closa, D. 2008. Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis. J. Gastrointest. Surg. 12: 891–899.
   PubMed Web of Science ®Google Scholar
• Furlong, C. E. 2007. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J. Biochem. Mol. Toxicol. 21: 197–205.
   PubMed Web of Science ®Google Scholar
• Furlong, C. E., Holland, N., Richter, R. J., Bradman, A., Ho, A., and Eskenazi, B. 2006. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet. Genomics 16:183–190.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G. L. 2012. Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 75: 374–390.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G. L., and Toal, B. F. 2009. Quantitative approach for incorporating methylmercury risks and omega-3 fatty acid benefits in developing species-specific fish consumption advice. Environ. Health Perspect. 117: 267–275.
   PubMed Web of Science ®Google Scholar
• Gonzalvo, M. C., Gil, F., Hernández, A. F., Villanueva, E., and Pla, A. 1997. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem. Biol. Interact. 105: 169–179.
   PubMed Web of Science ®Google Scholar
• Guallar, E., Sanz-Gallardo, M. I., van’t Veer, P., Bode, P., Aro, A., Gómez-Aracena, J., Kark, J. D., Riemersma, R. A., Martín-Moreno, J. M., and Kok, F. J. 2002. Mercury, fish oils, and the risk of myocardial infarction. Heavy Metals and Myocardial Infarction Study Group. N. Engl. J. Med. 347: 1747–1754.
   PubMed Web of Science ®Google Scholar
• Gupta, N., Binu, K. B., Singh, S., Maturu, N. V., Sharma, Y. P., Bhansali, A., and Gill, K. D. 2012. Low serum PON1 activity: An independent risk factor for coronary artery disease in North-West Indian type 2 diabetics. Gene 498: 13–19.
   PubMed Web of Science ®Google Scholar
• Hallgren, C. G., Hallmans, G., Jansson, J. H. Marklund, S. L., Huhtasaari, F., Schütz, A., Strömberg, U., Vessby, B., and Skerfving, S. 2001. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br. J. Nutr. 86: 397–404.
   PubMed Web of Science ®Google Scholar
• Harangi, M., Seres, I., Magyar, M. T., Csipo, I., Sipka, S., Valikovics, A., Csiba, L., Bereczki, D., and Paragh, G. 2008. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease. Cerebrovasc. Dis. 25: 122–128.
   PubMed Web of Science ®Google Scholar
• Hernández, A. F., Mackness, B., Rodrigo, L., López, O., Pla, A., Gil, F., Durrington, P. N., Pena, G., Parrón, T., Serrano, J. L., and Mackness, M. I. 2003. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure. Hum. Exp. Toxicol. 22: 565–574.
   PubMed Web of Science ®Google Scholar
• Hernández, A., Gómez, M. A., Pena, G., Gil, F., Rodrigo, L., Villanueva, E., and Pla, A. 2004. Effect of long-term exposure to pesticides on plasma esterases from plastic greenhouse workers. J. Toxicol. Environ. Health A 67: 1095–1108.
   PubMed Web of Science ®Google Scholar
• Hernández, A. F., Gil, F., Leno, E., López, O., Rodrigo, L., and Pla, A. 2009. Interaction between human serum esterases and environmental metal compounds. Neurotoxicology 30: 628–635.
   PubMed Web of Science ®Google Scholar
• Hine, D., Mackness, B., and Mackness, M. 2012. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation. IUBMB Life 64: 157–161.
   PubMed Web of Science ®Google Scholar
• Holzer, M., Trieb, M., Konya, V., Wadsack, C., Heinemann, A., Marsche, G. 2013. Aging affects high-density lipoprotein composition and function. Biochim. Biophys. Acta 1831: 1442–1448.
   PubMed Web of Science ®Google Scholar
• Jakubowski, H. 1999. Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 13: 2277–2283.
   PubMed Web of Science ®Google Scholar
• Jakubowski, H. 2000. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J. Biol. Chem. 275: 3957–3962.
   PubMed Web of Science ®Google Scholar
• Jakubowski, H. 2008. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol. 59( suppl. 9): 155–167.
   PubMedGoogle Scholar
• Jaouad, L., de Guise, C., Berrougui, H., Cloutier, M., Isabelle, M., Fulop, T., Payette, H., and Khalil, A. 2006. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydryl groups. Atherosclerosis 185: 191–200.
   PubMed Web of Science ®Google Scholar
• Jarvik, G. P., Rozek, L. S., Brophy, V. H., Hatsukami, T. S., Richter, R. J., Schellenberg, G. D., and Furlong, C. E. 2000. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler. Thromb. Vasc. Biol. 20: 2441–2447.
   PubMed Web of Science ®Google Scholar
• Johnsson, C., Schütz, A., and Sällsten, G. 2005. Impact of consumption of freshwater fish on mercury levels in hair, blood, urine, and alveolar air. J. Toxicol. Environ. Health A 68: 129–140.
   PubMed Web of Science ®Google Scholar
• Kamal, M., Fathy, M. M., Taher, E., Hasan, M., and Tolba, M. 2011. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers. Ann. Saudi Med. 31: 481–487.
   PubMed Web of Science ®Google Scholar
• Kotur-Stevuljevic, J., Spasic, S., Stefanovic, A., Zeljkovic, A., Bogavac-Stanojevic, N., Kalimanovska-Ostric, D., Spasojevic-Kalimanovska, V., and Jelic-Ivanovic, Z. 2006. Paraoxonase-1 (PON1) activity, but not PON1 (Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population. Clin. Chem. Lab. Med. 44: 1206–1213.
   PubMed Web of Science ®Google Scholar
• Kotur-Stevuljevic, J., Spasic, S., Jelic-Ivanovic, Z., Spasojevic-Kalimanovska, V., Stefanovic, A., Vujovic, A., Memon, L., and Kalimanovska-Ostric, D. 2008. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin. Biochem. 41: 1067–1073.
   PubMed Web of Science ®Google Scholar
• Koubaa, N., Nakbi, A., Hammami, S., Attia, N., Mehri, S., Ben Hamda, K., Ben Farhat, M., Miled, A., and Hammami, M. 2009. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome. Clin. Biochem. 42: 771–776.
   PubMed Web of Science ®Google Scholar
• Lacinski, M., Skorupski, W., Cieslinski, A., Sokolowska, J., Trzeciak, W. H., and Jakubowski, H. 2004. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Cell. Mol. Biol. 50: 885–893.
   PubMed Web of Science ®Google Scholar
• La Du, B. N., Aviram, M., Billecke, S., Navab, M., Primo-Parmo, S., Sorenson, R. C., and Standiford, T. J. 1999. On the physiological role(s) of the paraoxonases. Chem. Biol. Interact. 119–120:379–388.
   PubMed Web of Science ®Google Scholar
• Lara-Guzman, O. J., Tabares-Guevara, J. H., Leon-Varela, Y. M., Álvarez, R. M., Roldan, M., Sierra, J. A., Londoño-Londoño, J. A., and Ramirez-Pineda, J. R. 2012. Proatherogenic macrophage activities are targeted by the flavonoid quercetin. J. Pharmacol. Exp. Ther. 343: 296–306.
   PubMed Web of Science ®Google Scholar
• Lemos, N. B., Angeli, J. K., Faria Tde, O., Ribeiro Junior, R. F., Vassallo, D. V., Padilha, A. S., and Stefanon, I. 2012. Low mercury concentration produces vasoconstriction, decreases nitric oxide bioavailability and increases oxidative stress in rat conductance artery. PLoS One 7: e49005.
   PubMed Web of Science ®Google Scholar
• Li, W. F., Pan, M. H., Chung, M. C., Ho, C. K., and Chuang, H Y. 2006. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. Environ. Health Perspect. 114: 1233–1236.
   PubMed Web of Science ®Google Scholar
• Macharia, M., Hassan, M. S., Blackhurst, D., Erasmus, R. T., and Matsha, T. E. 2012. The growing importance of PON1 in cardiovascular health: A review. J. Cardiovasc. Med. 13: 443–453.
   Google Scholar
• Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M., and Mackness, M. 2003. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107: 2775–2779.
   PubMed Web of Science ®Google Scholar
• Mackness, M., and Mackness, B. 2004. Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important? Free Radical Biol. Med. 37: 1317–1323.
   PubMed Web of Science ®Google Scholar
• Mackness, M., Durrington, P., and Mackness, B. 2004. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Curr. Opin. Lipidol. 15: 399–404.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Quarck, R., Verreth, W., Mackness, M., and Holvoet, P. 2006. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 26: 1545–1550.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Beltran-Debon, R., Aragones, G., Joven, J., Camps, J., and Mackness, M. 2010. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 62: 480–482.
   PubMed Web of Science ®Google Scholar
• Mahaffey, K. R., Sunderland, E. M., Chan, H. M., Choi, A. L., Grandjean, P., Mariën, K., Oken, E., Sakamoto, M., Schoeny, R., Weihe, P., Yan, C. H., and Yasutake, A. 2011. Balancing the benefits of n-3 polyunsaturated fatty acids and the risks of methylmercury exposure from fish consumption. Nutr. Rev. 69: 493–508.
   PubMed Web of Science ®Google Scholar
• Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltrán, R., Joven, J., and Camps, J. 2008. Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radical Biol. Med. 45: 146–157.
   PubMed Web of Science ®Google Scholar
• Martinelli, N., Consoli, L., Girelli, D., Grison, E., Corrocher, R., and Olivieri, O. 2013. Paraoxonases: Ancient substrate hunters and their evolving role in ischemic heart disease. Adv. Clin. Chem. 2013: 59:65–100.
   Google Scholar
• McCully, K. S. 2009. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann. Clin. Lab. Sci. 39: 219–232.
   PubMed Web of Science ®Google Scholar
• Mendes, R. H., Sirvente, R. A., Candido, G. O., Mostarda, C., Salemi, V. M., D’Almeida, V., Jacob, M. H., Ribeiro, M. F., Belló-Klein, A., Rigatto, K., and Irigoyen, M. C. 2010. Homocysteine thiolactone induces cardiac dysfunction: Role of oxidative stress. J. Cardiovasc. Pharmacol. 55: 198–202.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., and Rimm, E. B. 2006. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. J. Am. Med. Assoc. 296: 1885–1899.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., Shi, P., Morris, J. S., Grandjean, P., Siscovick, D. S., Spiegelman, D., Willett, W. C., Rimm, E. B., Curhan, G. C., and Forman, J. P. 2012. Mercury exposure and risk of hypertension in US men and women in 2 prospective cohorts. Hypertension 60: 645–652.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., Shi, P., Morris, J. S., Spiegelman, D., Grandjean, P., Siscovick, D. S., Willett, W. C., and Rimm, E. B. 2011. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N. Engl. J. Med. 364: 1116–1125.
   PubMed Web of Science ®Google Scholar
• Muniz, J. F., McCauley, L., Scherer, J., Lasarev, M., Koshy, M., Kow, Y. W., Nazar-Stewart, V., and Kisby, G. E. 2008. Biomarkers of oxidative stress and DNA damage in agricultural workers: A pilot study. Toxicol. Appl. Pharmacol. 227: 97–107.
   PubMed Web of Science ®Google Scholar
• National Research Council. 2009. Science and decisions. Advancing risk assessment. Washington DC: National Academies Press.
   Google Scholar
• Nguyen, S. D., and Sok, D. E. 2003. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radical Res. 37:1319–1330.
   PubMed Web of Science ®Google Scholar
• Park, J. D., and Zheng, W. 2012. Human exposure and health effects of inorganic and elemental mercury. J. Prev. Med. Public Health 45: 344–352.
   PubMedGoogle Scholar
• Peng, W., Zhang, C., Lv, H., Zhu, J., Zang, Y., Pang, X., Zhang, J., and Qin, J. 2010. Comparative evaluation of the protective potentials of human paraoxonase 1 and 3 against CCl4-induced liver injury. Toxicol. Lett. 193: 159–166.
   PubMed Web of Science ®Google Scholar
• Permpongpaiboon, T., Nagila, A., Pidetcha, P., Tuangmungsakulchai, K., Tantrarongroj, S., and Porntadavity, S. 2011. Decreased paraoxonase 1 activity and increased oxidative stress in low lead-exposed workers. Hum. Exp. Toxicol. 30: 1196–1203.
   PubMed Web of Science ®Google Scholar
• Ratcliffe, H. E., Swanson, G. M., and Fischer, L. J. 1996. Human exposure to mercury: A critical assessment of the evidence of adverse health effects. J. Toxicol. Environ. Health 49: 221–270.
   PubMed Web of Science ®Google Scholar
• Rice, G. E., Hammitt, J. K., and Evans, J. S. 2010. A probabilistic characterization of the health benefits of reducing methyl mercury intake in the United States. Environ. Sci. Technol. 44: 5216–5224.
   PubMed Web of Science ®Google Scholar
• Roman, H. A., Walsh, T. L., Coull, B. A., Dewailly, É., Guallar, E., Hattis, D., Mariën, K., Schwartz, J., Stern, A. H., Virtanen, J. K., and Rice, G. 2011. Evaluation of the cardiovascular effects of methylmercury exposures: Current evidence supports development of a dose-response function for regulatory benefits analysis. Environ. Health Perspect. 119: 607–614.
   PubMed Web of Science ®Google Scholar
• Rozenberg, O., Rosenblat, M., Coleman, R., Shih, D. M., and Aviram, M. 2003. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice. Free Radical Biol. Med. 34: 774–784.
   PubMed Web of Science ®Google Scholar
• Rozenberg, O., Shih, D. M., and Aviram, M. 2005. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: Studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 181: 9–18.
   PubMed Web of Science ®Google Scholar
• Salonen, J. T., Seppänen, K., Lakka, T. A., Salonen, R., and Kaplan, G. A. 2000. Mercury accumulation and accelerated progression of carotid atherosclerosis: A population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148: 265–273.
   PubMed Web of Science ®Google Scholar
• Schwartz, J. 1994. Societal benefits of reducing lead exposure. Environ. Res. 66: 105–124.
   PubMed Web of Science ®Google Scholar
• Selek, S., Aslan, M., Horoz, M., Gur, M., and Erel, O. 2007. Oxidative status and serum PON1 activity in beta-thalassemia minor. Clin. Biochem. 40: 287–291.
   PubMed Web of Science ®Google Scholar
• Sentürk, T., Sarandöl, E., Güllülü, S., Erdinç, S., Ozdemir, B., Baran, I., and Aydinlar, A. 2008. Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes. Acta Cardiol. 63: 361–367.
   PubMed Web of Science ®Google Scholar
• Shih, D. M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., and Lusis, A. J. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394: 284–287.
   PubMed Web of Science ®Google Scholar
• Sibrian-Vazquez, M., Escobedo, J. O., Lim, S., Samoei, G. K., and Strongin, R M. 2010. Homocystamides promote free-radical and oxidative damage to proteins. Proc. Natl. Acad. Sci. USA 107: 551–554.
   PubMed Web of Science ®Google Scholar
• Sirivarasai, J., Kaojarern, S., Sura, T., and Yoovathaworn, K. 2011. Biochemical, environmental, and genetic factors associated with paraoxonase (PON1) activity. Biochem. Genet. 49: 364–368.
   PubMed Web of Science ®Google Scholar
• Skoczyńska, A., Poreba, R., Steinmentz-Beck, A., Martynowicz, H., Affelska-Jercha, A., Turczyn, B., Wojakowska, A., and Jedrychowska, I. 2009. The dependence between urinary mercury concentration and carotid arterial intima-media thickness in workers occupationally exposed to mercury vapour. Int. J. Occup. Med. Environ. Health 22: 135–142.
   PubMed Web of Science ®Google Scholar
• Soltaninejad, K., and Abdollahi, M. 2009. Current opinion on the science of organophosphate pesticides and toxic stress: A systematic review. Med. Sci. Monit. 15: RA75–RA90.
   PubMed Web of Science ®Google Scholar
• Sözmen, E. Y., Mackness, B., Sözmen, B., Durrington, P., Girgin, F. K., Aslan, L., and Mackness, M. 2002. Effect of organophosphate intoxication on human serum paraoxonase. Hum. Exp. Toxicol. 21: 247–252.
   PubMed Web of Science ®Google Scholar
• Sözmen, B., Peker, S., Kaya, U., Erkan, M., and Sözmen, E. Y. 2007. Markers of long-term exposure to organophosphorus pesticides in farmers who work in viniculture and tobacco production in Turkey. Toxicol. Mech. Methods 17: 379–384.
   PubMed Web of Science ®Google Scholar
• Swardfager, W., Herrmann, N., Cornish, S., Mazereeuw, G., Marzolini, S., Sham, L., and Lanctôt, K. L. 2012. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. Am. Heart J. 163: 666–676.
   PubMed Web of Science ®Google Scholar
• Sweet, L. I., and Zelikoff, J. T. 2001. Toxicology and immunotoxicology of mercury: A comparative review in fish and humans. J. Toxicol. Environ. Health B 4:161–205.
   PubMed Web of Science ®Google Scholar
• Tang, W. H., Wu, Y., Mann, S., Pepoy, M., Shrestha, K., Borowski, A. G., and Hazen, S. L. 2011. Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure. Circ. Heart Fail. 4: 259–264.
   Google Scholar
• Tang, W. H., Hartiala, J., Fan, Y., Wu, Y., Stewart, A. F., Erdmann, J., Kathiresan, S., The CARDIoGRAM Consortium, Roberts, R., McPherson, R., Allayee, H., and Hazen, S. L. 2012. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 32: 2803–2812.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 2001. IRIS summary for methyl mercury. http://www.epa.gov/iris/subst/0073.htm (accessed October 24, 2012).
   Google Scholar
• Vassallo, D. V., Simões, M. R., Furieri, L. B., Fioresi, M., Fiorim, J., Almeida, E. A., Angeli, J. K., Wiggers, G. A., Peçanha, F. M., and Salaices M. 2011. Toxic effects of mercury, lead and gadolinium on vascular reactivity. Braz. J. Med. Biol. Res. 44: 939–946.
   PubMed Web of Science ®Google Scholar
• Virtanen, J. K., Rissanen, T. H., Voutilainen, S., and Tuomainen, T. P. 2007. Mercury as a risk factor for cardiovascular diseases. J. Nutr. Biochem. 18: 75–85.
   PubMed Web of Science ®Google Scholar
• Vos, E. 2008. Homocysteine levels, paraoxonase 1 (PON1) activity, and cardiovascular risk. J. Am. Med. Assoc. 300: 168–169.
   Web of Science ®Google Scholar
• Wang, M., Lang, X., Zou, L., Huang, S., and Xu, Z. 2011. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case-control studies. Atherosclerosis 214: 377–385.
   PubMed Web of Science ®Google Scholar
• Xue, J., Zartarian, V. G., Liu, S. V., and Geller, A. M. 2012. Methyl mercury exposure from fish consumption in vulnerable racial/ethnic populations: probabilistic SHEDS-Dietary model analyses using 1999-2006 NHANES and 1990-2002 TDS data. Sci. Total Environ. 414: 373–379.
   PubMed Web of Science ®Google Scholar
• Yoshida, H., and Kisugi, R. 2010. Mechanisms of LDL oxidation. Clin. Chim. Acta 411: 1875–1882.
   PubMed Web of Science ®Google Scholar
• Zhang, C., Peng, W., Wang, M., Zhu, J., Zang, Y., Shi, W., Zhang, J., and Qin, J. 2010. Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice. Gene Ther. 17: 626–633.
   PubMed Web of Science ®Google Scholar